High Tower Advisors, LLC Aim Immuno Tech Inc. Transaction History

High Tower Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.67 - $1.18 $16,103 - $28,361	-24,035 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$0.92 - $1.96 $15,695 - $33,437	-17,060 Reduced 41.51%	24,035 $22,000
Q3 2021 Nov 12, 2021	SELL	$1.91 - $2.17 $49,805 - $56,584	-26,076 Reduced 38.82%	41,095 $82,000
Q2 2021 Aug 06, 2021	BUY	$1.93 - $2.39 $7,866 - $9,741	4,076 Added 6.46%	67,171 $144,000
Q1 2021 May 10, 2021	BUY	$1.88 - $2.82 $118,618 - $177,927	63,095 New	63,095 $143,000
Q4 2020 Feb 10, 2021	SELL	$1.68 - $2.45 $117,600 - $171,500	-70,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$1.77 - $3.88 $70,800 - $155,200	40,000 Added 133.33%	70,000 $151,000
Q2 2020 Aug 10, 2020	BUY	$1.9 - $2.94 $57,000 - $88,200	30,000 New	30,000 $75,000

9.01M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $11.1M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.